← All companies

REGN — REGENERON PHARMACEUTICALS, INC.

Materials · Pharmaceutical Preparations · Nasdaq

CIK 0000872589 · FYE 1231 · All Form 4 filings on EDGAR ↗

Formerly: REGENERON PHARMACEUTICALS INC (until 2019-06-19)

1Insiders filing

3Transactions

+$4.7MReported buys

−$7.5MReported sells

0Cluster events

Window in data: 2026-08-19 → 2026-08-19 · Data as of 2026-08-28

Insiders

Insider	Role	Txns	Reported value
LAROSA JOSEPH J	EVP General Counsel and Secret	3	$12.2M

Transaction history

Filing date	Trade date	Ticker	Insider	Type	Shares	Price	Value	Cluster
2026-08-21	2026-08-19	REGN	LAROSA JOSEPH J EVP General Counsel and Secret	M routine	12,282	$381.92	+$4.7M	—
2026-08-21	2026-08-19	REGN	LAROSA JOSEPH J EVP General Counsel and Secret	F routine	9,019	$830.15	−$7.5M	—
2026-08-21	2026-08-19	REGN	LAROSA JOSEPH J EVP General Counsel and Secret	M routine	12,282	—	—	—

Known data limitations

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Insider Atlas is a descriptive research site, not investment advice — see the methodology for the full provenance chain.